Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2005
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222185 Nucleoside derivatives and therapeutic uses therof
10/06/2005US20050222184 Process for preparing (s)-tetrahydro-a-(1-methylethyl)-2-oxo-1(2h)-pyrimidineacetic acid
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222150 6-(p-morpholinoanilino)-4-(4-substituted-1-piperazinyl)-2-(methylthio)pyrimidines having an excellent inhibitory effect on replication of Hepatitis C virus
10/06/2005US20050222141 N-(2,6-dichlorobenzoyl)-4-[1-methyl-7-(pyrrolidine-1-ylmethyl)-2,4-quinazoline-dione-3-yl]-L-phenylalanine trifluoroacetate; 4 integrin antagonist; antiinflammatory, anticarcinogenic agent, antiallergent; asthma, psoriasis, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation
10/06/2005US20050221990 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/05/2005EP1582516A1 Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same
10/05/2005EP1581498A2 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581478A1 Dhodh-inhibitors and method for their identification
10/05/2005EP1581477A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP0775110B1 Arylthio compounds as antibacterial and antiviral agents
10/05/2005CN1678614A Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/05/2005CN1678613A Hetereoaryl nitrile derivatives
10/05/2005CN1678592A 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678590A Amide derivative and medicine
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1676519A Chrysanthemacyl thiourea pyrimidine derivative with bioactivity, and its preparing method and pesticide composition
10/05/2005CN1221537C Epimino substituted benzene derivative
10/05/2005CN1221536C New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005US6951937 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
10/04/2005US6951877 Materials and methods for treating hypercholesterolemia
10/04/2005US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
09/2005
09/29/2005WO2005090322A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005089511A2 Novel pharmaceutical forms, and methods of making and using the same
09/29/2005WO2005065183A3 Mitotic kinesin inhibitors
09/29/2005WO2005063721B1 Herbicidal pyrimidines
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215790 Reacting an aldehyde, a beta -keto ester and urea or thiourea in the presence of a polyaniline salt catalyst and separating the substituted dihydropyrimidinone obtained thereby
09/29/2005US20050215789 Production method of aminopyrimidine compound
09/29/2005US20050215783 Thiourea compositions and uses thereof
09/29/2005US20050215574 4-anilino quinazoline derivatives as antiproliferative agents
09/29/2005US20050214249 Release nitric oxide under physiological conditions and are useful for treating biological disorders
09/29/2005DE102004001873A1 Cyanopyrimidinone Cyanopyrimidinone
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2559196A1 Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents
09/29/2005CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1579874A2 Conjugate having a cleavable linkage for use in a liposome
09/28/2005EP1578757A2 Fluorogenic enzyme substrates and methods of preparation
09/28/2005EP1578748A1 Tetrahydro-4h-pyrido [1, 2-a] pyrimidines and related compounds useful as hiv integrase inhibitors
09/28/2005EP1578741A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/28/2005EP1578733A1 Process for the preparation of rosuvastatin
09/28/2005EP1578731A2 Process for the preparation of pyrimidine compounds
09/28/2005EP1578722A2 Kinase inhibitor scaffolds and methods for their preparation
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1163227B1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/28/2005EP1132387B1 Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultural/horticultural fungicides
09/28/2005EP1036319B1 Process for obtaining l-dihydroorotic acid and use thereof
09/28/2005CN1675322A Printing process using specified azo compounds
09/28/2005CN1675225A Macrocyclic pyrimidines, their production and use as pharmaceutical agents
09/28/2005CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
09/28/2005CN1675184A Caspase inhibitors and uses thereof
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/28/2005CN1673219A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
09/28/2005CN1220684C 2, 4, Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220682C Heterocycle derivatives inhibiting factor Xa
09/27/2005US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease.
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/27/2005US6949557 Hydroanthracene based compounds as anticancer agents
09/27/2005US6949551 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949521 Therapeutic azide compounds
09/22/2005WO2005087749A1 2-aminoquinazoline derivative
09/22/2005WO2005087227A1 Arylalkylamino-substituted quinazoline analogues
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005074654A3 Methods to manufacture 1,3-dioxolane nucleosides
09/22/2005WO2005068445A3 Pesticidal heterocyclic dihaloallyl compounds
09/22/2005WO2004060376A8 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
09/22/2005US20050209338 Phenethanolamine derivatives for treatment of respiratory diseases
09/22/2005US20050209261 Rho-kinase inhibitors
09/22/2005US20050209260 Purinergic receptor antagonists; genitourinary and pain-related diseases; for example, 5-(2-isopropyl-4,5-dimethoxybenzyl)-pyrimidine-2,4-diamine
09/22/2005US20050209257 5-Protected aminopyrimidine compound, production method thereof and intermediate therefor
09/22/2005US20050209254 Kinesin spindle protein (KSP) inhibitors; 2-substituted 4-(thio)oxo-3,4-dihydroquinazolines; use in combination with other anticancer agents
09/22/2005US20050209241 Benzoyl-piperazine derivatives
09/22/2005US20050209231 In embryonic stem cells in vitro and in vivo; cardiomyopathy; 2,6-diaminopyrimidine compounds
09/22/2005US20050209230 2,4-Pyrimidinediamine compounds and their uses
09/22/2005US20050209229 Form 3 ZD1839 dimethylsulfoxide solvate; ZD1839 is known as the tradename Iressa and as gefitinib
09/22/2005US20050209221 Pyrimidine or pyridine carboxamides or pharmaceutically-acceptable salts thereof, for example, 1,1-dimethylethyl 4-(4-((5-(((2,6-dimethylphenyl)amino)carbonyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)oxy)phenyl)-1-piperazinecarboxylate; for protein tyrosine kinase-associated disorders
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005DE19513006B4 Flüssigkristallines Medium und seine Verwendung Liquid-crystalline medium and its use
09/22/2005CA2560098A1 2-aminoquinazoline derivative
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2557779A1 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds